Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the response rate to the combination of doxorubicin
and valproate acid in patients with MM failing after at least one previous chemotherapy
regimen including platinum derivatives .